Replies to post #116926 on Progressive Care Inc (fka RXMD)

[Jimmy Quick]

AND THEN THE TRUTH BE TOLD BELOW

RXMD’s GREATNESS AS AN UNDERVALUED OTCQB STOCK

OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS


RXMD Revenues and Scripts per location, Second to None


RXMD Compared to the Competition WOWSERS!!!


Penny Stock Exempt with low Share Structure


RXMD Retail Stores Commence Major Expansion Across Florida


RXMD 5 Star Humana Rating Earns Them Highest Payout


CEO IS PRETTY, and REALLY SMART


PHARMCORX HAS SMARTPACK, EXACT SAME AS PILLPACK


3 YEARS AUDITED F/S


IMPROVED FUNDING AGREEMENTS FOR ACQUISITIONS and NEW HEADQUARTERS


HINT HINT!!! RXMD SERVICE PROVIDERS


RXMD Price Target, prior to any acquisitions. HINT HINT


Big Mistake Spot Last Year
Sell of shares at $.019

[Jimmy Quick]

ONLY FOLLOWING RXMD STOCK

THAT SEEMS LIKE A GIMMICK TO ME

RXMD INSIDERS ARE VERY HAPPY WITH THEIR INVESTMENT

FREE SHARES DISBURSED LAST YEAR, ALREADY WORTH 6 TIMES WHAT THEY WERE LAST YEAR, AND SO ARE MINE!

AND WITH SEC REGISTRATION THEY WILL BE WORTH 6 TIMES WHAT THEY ARE NOW!

THANKS FOR THE CONTINUED ATTENTION HERE!

[Jimmy Quick]

SEC REGISTRATION - NO GIMMICK
SEC and Uplisting: The Company will be preparing the new acquisition for 2 years of audited financial statements for inclusion in an S-1 by the end of 2019. This process will bring the Company to full reporting status with the SEC and begin the next stage in uplisting to a national exchange like NASDAQ. Progressive Care also announced that it is planning a shareholder meeting to be scheduled in the near future.

Acquisition: The Company has filed its required advanced notification to Florida’s Medicaid Agency. The Acquisition is on track for a hard close in May/ Early June 2019 at which point FPRX, with its 2 cash flow positive Florida locations, will consolidate in the Company financial results which is projected to bring the Company to over $30 million in annual revenues for fiscal year 2019 and over $40 million in revenue for 2020.

[Jimmy Quick]

SEC REGISTRATION - NO GIMMICK

Progressive Care OUTLOOK
The following are our strategic goals for 2019:
• Achieve 40,000 prescriptions filled in a single month
• Increase annual same store sales to $24 million
• Close on second acquisition leading to consolidated revenue of over $35 million
• Secure additional 340B contracts and long-term care facility relationships
• Achieve accreditation for non-sterile compounding
• Achieve full enterprise profitability and earnings growth
• Install Tele-PharmCo enabled kiosks and equipment in senior living communities and large-scale clinics
• Develop exclusive line of CBD products
• Conduct PharmCo evidence-based case studies
• Release PharmCo's first televised advertisement
• Become SEC registered and fully reporting